The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH

Jul 30, 2024

- Jul 29, 2025

1.0

Claim your AMA PRA Category 1 Credit(s) credit

Already have an Account? Log In
Don’t have an account? Register Today

Claim your Certificate

Des experts internationaux évaluent de nouvelles données sur l’inhibition de l’aldostérone...

Integrating Next-Generation Acid Suppression into Practical Algorithms for Gastroenterolog...

PCSK9 Inhibitors in Primary Prevention: A New Paradigm for Family Physicians